Medisch Centrum Latem
- Address
- lock Available on a paid plan
Medisch Centrum Latem - Osteoarthritis Research
Medisch Centrum Latem is a specialized clinical research facility dedicated to advancing the treatment of musculoskeletal disorders, with particular expertise in degenerative joint diseases. The center focuses on evaluating innovative therapeutic approaches for patients suffering from chronic joint conditions.
- Intra-articular therapy development for osteoarthritis
- Pharmacokinetic studies of novel joint-targeted treatments
- Safety and tolerability assessment in degenerative joint disease
The research center has established comprehensive capabilities in conducting early-phase clinical trials for knee osteoarthritis, specializing in the evaluation of investigational compounds across various disease severity stages, from moderate Kellgren and Lawrence grade 2 to advanced grade 4 osteoarthritis. Their work contributes to the development of targeted therapeutic options aimed at improving outcomes for patients with debilitating joint conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medisch Centrum Latem
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Safety, Tolerability, and Pharmacokinetics of Intra-Articular 4P-004 in Patients with Kellgren and Lawrence Grade 2-4 Knee Osteoarthritis | 4moving Biotech | Phase I | Not Recruiting | May 2023 | Oct 2023 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Liraglutide | 1 | Unknown | 2023-05-10 | 2023-05-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.